Ideas to action: independent research for global prosperity
Search
Filters:
Experts
Facet Toggle
Topics
Facet Toggle
Content Type
Facet Toggle
Publication Type
Facet Toggle
Time Frame
Facet Toggle
Blog Post
December 21, 2022
If economists are the ‘dismal scientists’ always harping on about limited resources, evaluators are often considered the ‘pessimist scientists’ who only see the half-empty glass, rather than the half-full one. The end of the year is, however, a perfect time to break with that tradition. It is a time...
Blog Post
December 14, 2022
It’s clear that COVID-19 oral antivirals are effective, and recent deals have made them even cheaper for African countries. But should these countries be investing in these medicines? Or would spending on alternative health services be better value for money? Unfortunately, there is very little avai...
Blog Post
December 14, 2022
Four new CGD pieces, released today, examine the current state of play on COVID-19 oral antivirals. Our analyses provide a deep-dive in key cross-cutting areas—demand, voluntary licensing deals for generic supply, and deployment—and offer policy actions for 2023 and beyond.
BRIEFS
December 08, 2022
Drug-resistant infections kill an estimated 5,400 Canadian citizens every year. Without sufficient R&D investment for new antimicrobials, deaths from drug-resistant infections could increase dramatically in the coming decade. We present the results of a modelling exercise to estimate the likely ROI ...
POLICY PAPERS
November 28, 2022
The experience of the COVID-19 pandemic—in the US and around the world—highlights the potential feasibility and importance of biomedical R&D for global health and welfare. Drawing from this experience and momentum, this paper argues that the US should deepen its engagement and ambition in global hea...
Blog Post
November 28, 2022
Building on the success of Operation Warp Speed, the US should deepen its engagement and ambition in global health R&D to drive transformative improvements in global health outcomes and security. Specifically, it should consider a subscription model for new antimicrobials; an advance market commitme...
Blog Post
November 25, 2022
COP27, just concluded in Sharm El-Sheikh, was dubbed the ‘implementation COP’ by its Egyptian hosts. But it’s very difficult to implement without workers. The COP27 agreement emphasises that a “just and equitable transition” must include “workforce and other dimensions.” This short, vague language c...
Blog Post
November 23, 2022
Living up to the challenge of limiting global temperature rise to 1.5°C, especially after meagre emission reduction outcomes at COP 27, will not only require much more finance but also much more effective climate finance—from both the public and private sectors. The world will need to develop new te...